Trustar Capital Reduces Its Stake at TAUNS Laboratories’s IPO
20 Jun 2024
US$ 19.00
Trustar Capital (Trustar) has pared down its interest in TAUNS Laboratories Inc (TAUNS) at the latter’s ¥9.7 billion (U...
Related Publications
Actis announced the final closing of its Actis Long Life Infrastructure Fund 2 (Actis Infra 2), at US$1.7 bn ......
The Guardians of New Zealand Superannuation (the Guardians), manager of the New Zealand Superannuation Fund, has ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.